The PennyShac

[Pennypicks]

GMED November 20-21,2003 - CEO is a Confirmed Speaker For Cancer Drug Research and Development

http://gtcbio.com/index.asp

Confirmed Speakers For Cancer Drug Research and Development



Tony Hunter

Keynote Speaker, Professor, Salk Institute


David Chaplin

Chief Scientific Officer, Oxigene


Jocelyn Holash

Regeneron


Steve Harrison

Director, Chiron


Rama Krishna Narla

Celgene


Shanta Bantia

Director, BioCryst Pharmaceuticals


Oren Beske

Head of Cell Biology, Vitra Bioscience, Inc.


Ben Tseng

Vice president, Maxim Pharmaceuticals


Sergey M. Kipriyanov

Head of Antibody Engineering, Affimed Therapeutics AG


Chaoyong Ma

Business Development Manager, Phylonix Pharmaceuticals, Inc.


Sandra Chica

Medical Director, Perceptive Informatics, Inc


Mark Rolfe

Sr. Director, Millennium Pharmaceuticals, Inc.


Patrick O'Connor

Pfizer, Invited


David W. Moskowitz

Chairman, Chief Executive Officer, and Chief Medical Officer, GenoMed, Inc.


Ricky Johnstone

Group Leader, Gene Regulation Laboratory
Cancer Immunology Division
The Peter MacCallum Cancer Institute


Guha Krishnaswamy

Professor of Medicine, Chief, Division of Allergy and Immunology, James H. Quillen V.A. Medical Center, James H. Quillen College of Medicine


Peter M. Fischer

Head, Discovery Research
Cyclacel Limited


Janice L Huff

Director of the Cell and Molecular Biology Research, BioForce


Julian Woelcke